Dermal Cell News Volume 7.01 | Jan 11 2021

    0
    70








    2021-01-11 | DCN 7.01


    Dermal Cell News by STEMCELL Technologies
    Vol. 7.01 – 11 January, 2021
    TOP STORY

    Topical Application of Peptide-Chondroitin Sulfate Nanoparticles Allows Efficient Photoprotection in Skin

    The authors describe a method of delivery of chondroitin sulfate to the skin as nanoparticles and demonstrated its anti-inflammatory and antioxidant role using UV irradiation as a model condition.
    [ACS Applied Materials & Interfaces]

    AbstractGraphical Abstract

    Connect with us via LiveChat to ask your scientific support questions
    PUBLICATIONSRanked by the impact factor of the journal
    DERMAL STEM CELLS & TISSUE REGENERATION

    Metabolomic Profile and Antioxidant/Anti-Inflammatory Effects of Industrial Hemp Water Extract in Fibroblasts, Keratinocytes and Isolated Mouse Skin Specimens

    The phenolic and terpenophenolic compounds were assayed in the water extract of the hemp variety Futura 75. Protective effects were also investigated in human fibroblast and keratinocytes and isolate mouse skin specimens, which were exposed to hydrogen peroxide and/or to the extract.
    [Antioxidants]

    Full Article

    IL-10 Alleviates Lipopolysaccharide-Induced Skin Scarring via IL-10R/STAT3 Axis Regulating TLR4/NF-κB Pathway in Dermal Fibroblasts

    Scientists investigated whether IL‐10 alleviated lipopolysaccharide‐induced inflammatory response and skin scarring and explored the possible mechanism of scar formation.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    Octenidine-Based Hydrogel Shows Anti-Inflammatory and Protease-Inhibitory Capacities in Wounded Human Skin

    Proteomics analysis of octenidine dihydrochloride-treated skin wounds revealed significantly lower levels of key players in tissue remodeling as well as reepithelization after wounding such as pro-inflammatory cytokines and matrix-metalloproteinases when compared to controls.
    [Scientific Reports]

    Full Article

    Carbon Dioxide Inhibits UVB-Induced Inflammatory Response by Activating the Proton-Sensing Receptor, GPR65, in Human Keratinocytes

    Researchers examined the anti-inflammatory effects of carbon dioxide (CO2) in human keratinocytes and skin. Keratinocytes were cultured under 15% CO2, irradiated with ultraviolet B (UVB), and their inflammatory cytokine production was analyzed.
    [Scientific Reports]

    Full Article

    Localization and Regulation of Cholesterol Transporters in the Human Hair Follicle: Mapping Changes Across the Hair Cycle

    The authors demonstrated the capacity of human hair follicles for cholesterol transport and trafficking.
    [Histochemistry and Cell Biology]

    Full Article

    EGFR Inhibitors Switch Keratinocytes from a Proliferative to a Differentiative Phenotype Affecting Epidermal Development and Barrier Function

    The effects of Epidermal Growth Factor Receptor inhibitors (EGFRi) and Vascular Endothelial Growth Factor Receptor inhibitors at therapeutically relevant concentrations were assessed on proliferation and differentiation markers of human keratinocytes in a novel 3D micro-epidermis tissue culture model.
    [BMC Cancer]

    Full Article

    SKIN CANCERS & DISORDERS

    Discovery of a New Molecule Inducing Melanoma Cell Death: Dual AMPK/MELK Targeting for Novel Melanoma Therapies

    CRO15 exerted anti-melanoma effects on cells lines and cells isolated from patients including the ones derived from tumors resistant to BRAF inhibitor
    [Cell Death & Disease]

    Full Article

    Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells

    Scientists investigated the mechanism of metastasis in highly metastatic melanoma and breast cancer cells, and the mechanism of inhibition of metastasis by rhosin.
    [Biomedicines]

    Full Article

    Tracking of Glycans Structure and Metallomics Profiles in BRAF Mutated Melanoma Cells Treated with Vemurafenib

    Investigators presented the action of the B-Raf serine-threonine protein kinase inhibitor (vemurafenib) on the glycans structure and metallomics profiles in melanoma cells without and with BRAF mutations.
    [International Journal of Molecular Sciences]

    AbstractFull ArticleGraphical Abstract

    Comprehensive Upstream and Downstream Regulatory Analyses Identify miR-675-3p as a Potential Prognostic Biomarker in Melanoma

    Researchers assessed miR-675-3p-related regulatory mechanisms in melanoma and the clinical relevance of such regulatory activities.
    [Human Cell]

    Full Article

    Explore scientific events this January with the Science Events Calendar.
    REVIEWS

    The State of Melanoma: Emergent Challenges and Opportunities

    The authors discuss the progress made since the last Melanoma Research Foundation assessment, comment on what remains to be overcome, and offer recommendations for the best path forward.
    [Clinical Cancer Research]

    Abstract

    INDUSTRY AND POLICY NEWS

    InMed Announces Results of Second Phase I Clinical Trial of INM-755 CBN Cream in Healthy Subjects

    InMed Pharmaceuticals Inc. announced top-line results from its 755-102-HV Phase I clinical trial. Results of the study indicate that INM-755 cream was safe and well-tolerated on induced open epidermal wounds, caused no systemic or serious adverse effects, and there were no subject withdrawals due to adverse events.
    [InMed Pharmaceuticals Inc.]

    Press Release

    Istari Oncology Announces FDA Grants Orphan Drug Designation for PVSRIPO for the Treatment of Advanced Melanoma

    Istari Oncology, Inc. announced that the FDA has granted orphan drug designation for PVSRIPO for the treatment of advanced melanoma. PVSRIPO is a novel viral immunotherapy, based on the Sabin type 1 polio vaccine, that activates a patient’s innate and adaptive immune system to facilitate an anti-tumor response and establish long-term immunologic memory to help prevent the cancer’s return.
    [Istari Oncology, Inc.]

    Press Release

    FEATURED EVENT

    Integrating Metabolism and Immunity

    January 25 – 28, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Scientific Communities & Communications Specialist

    STEMCELL Technologies, Inc. – Burnaby, British Columbia, Canada

    Senior Manager – FACS-Based Characterization

    Fondazione Human Technopole – Milan, Italy

    Postdoctoral Fellow – Wound Healing and/or Dermatology

    The University of British Columbia – Vancouver, British Columbia, Canada

    Postdoctoral Research Scientist – Dermatology

    Columbia University Medical Center – New York, New York, United States

    Associate Professor – Cancer Biology

    University of Cincinnati – Cincinnati, Ohio, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Dermal Cell News Archives Contact Us
    Dermal Cell News Twitter